Galmed Pharmaceuticals Statistics
Total Valuation
GLMD has a market cap or net worth of $1.71 million. The enterprise value is -$9.21 million.
Market Cap | 1.71M |
Enterprise Value | -9.21M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
Earnings Date | Aug 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GLMD has 6.01 million shares outstanding.
Shares Outstanding | 6.01M |
Owned by Insiders (%) | 3.66% |
Owned by Institutions (%) | 3.04% |
Float | 5.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.13 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.34, with zero debt.
Current Ratio | 6.34 |
Quick Ratio | 6.34 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 12.90 |
Financial Efficiency
Return on equity (ROE) is -48.30% and return on invested capital (ROIC) is -54.02%.
Return on Equity (ROE) | -48.30% |
Return on Assets (ROA) | -41.00% |
Return on Capital (ROIC) | -54.02% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.12M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.63% in the last 52 weeks. The beta is 0.80, so GLMD's price volatility has been lower than the market average.
Beta (5Y) | 0.80 |
52-Week Price Change | -90.63% |
50-Day Moving Average | 0.36 |
200-Day Moving Average | 0.39 |
Relative Strength Index (RSI) | 34.49 |
Average Volume (20 Days) | 65,742 |
Short Selling Information
Short Interest | 13,731 |
Short Previous Month | 23,799 |
Short % of Shares Out | 0.22% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.22 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -6.89M |
Pretax Income | -6.36M |
Net Income | -6.36M |
EBITDA | -6.86M |
EBIT | -6.89M |
Earnings Per Share (EPS) | -$2.40 |
Balance Sheet
The company has $10.93 million in cash and no debt, giving a net cash position of $10.93 million or $1.82 per share.
Cash & Cash Equivalents | 10.93M |
Total Debt | n/a |
Net Cash | 10.93M |
Net Cash Per Share | $1.82 |
Equity (Book Value) | 12.76M |
Book Value Per Share | 2.12 |
Working Capital | 9.42M |
Cash Flow
Operating Cash Flow | -6.27M |
Capital Expenditures | n/a |
Free Cash Flow | -6.27M |
FCF Per Share | -$1.15 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GLMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -222.67% |
Shareholder Yield | -222.67% |
Earnings Yield | -370.77% |
FCF Yield | -365.81% |
Analyst Forecast
The average price target for GLMD is $4.00, which is 1,302.03% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.00 |
Price Target Difference | 1,302.03% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 15, 2023. It was a reverse split with a ratio of 1:15.
Last Split Date | May 15, 2023 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |